184
Results-
NewsRecent updates in BRAFV600E-mutant metastatic colorectal cancer treatmentCreated on : - Last modified on :In 2020, almost two million people were diagnosed with colorectal cancer (CRC)1. At present, survival rates for the metastatic CRC (mCRC) population are poor, with less than 20% of people living for more than five years after diagnosis across Europe. Of these patients, 8-12% are diagnosed with a BRAF mutation, 95% of which are BRAFV600E, an aggressive form associated with a poor prognosis.2
-
NewsThe Pierre Fabre group, Platinum Sponsor at the 25th World Congress of Dermatology in SingaporeCreated on : - Last modified on :From July 3rd to 8th, 2023, The Pierre Fabre group, 2nd largest dermo-cosmetics laboratory in the world and 2nd largest private pharmaceutical group in France, will be actively participating in the 25th World Congress of Dermatology in Singapore. As a platinum sponsor of the event, the Group demonstrates its commitment to advancing research and innovation in the specialized fields of dermatology and oncology.
-
NewsTHE GREEN IMPACT INDEX CONSORTIUM IS PLEASED TO ANNOUNCE THE PUBLICATION OF AFNOR SPEC 2215 BY AFNOR:Created on : - Last modified on :The first guide to displaying the environmental and societal impact of cosmetics, food supplements, family health and wellness products, available to all companies, from SMEs to major international groups.
-
NewsMetastatic Colorectal Cancer World DayCreated on : - Last modified on :Knowing your biomarker can make the difference. Ask your healthcare team to learn more
-
NewsPierre Fabre and startups CareOS and Revieve are launching a connected mirror for skin diagnosisCreated on : - Last modified on :Pierre Fabre Group, CareOS and Revieve announced the conclusion of a partnership initiated in May 2019 with the exclusive experience of a new model of connected mirror capable of customized skin diagnosis.
-
NewsThe Pierre Fabre Group unveils its PurposeCreated on : - Last modified on :The Group is unveiling its purpose today on social media via an extensive campaign reaching our various audiences. A purpose oriented toward a better world. This campaign is launched with a column published on Linkedin by Éric Ducournau, CEO of the Pierre Fabre group.
-
NewsPIERRE FABRE CONFIRMED AS ONE OF THE WORLD’S BEST EMPLOYERSCreated on : - Last modified on :For the 3rd year in a row, Pierre Fabre Laboratories is proud to be listed in the World’s Best Employers ranking. This ranking, compiled by the American magazine FORBES and the independent German market research firm Statista, places Pierre Fabre at Top 6 among cosmetic companies and Top 7 among pharmaceutical companies.
-
NewsA Passionate Medical Science Liaison (MSL) Advancing Healthcare in AustraliaCreated on : - Last modified on :The script of the video:
-
NewsA Passionate Medical Science Liaison (MSL) Advancing Healthcare in PolandCreated on : - Last modified on :
-
NewsDiscover the Pierre Fabre Laboratories 2024 annual report!Created on : - Last modified on :Introduced in the editorial by Eric Ducournau, CEO, “Pierre Fabre: Relentlessly innovating", the annual report this year is organized around our Group signature “New ways to care."
We take care of life by designing and developing innovative solutions inspired by consumers and patients, and contributing to the well-being of everyone from health to beauty.